Researchers define the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an progressive solid-tumor cancer into long-term remission. A team led by Cassian Yee, M.D., an corollary




if (lexico_globals.googleafc.ads.content.length)
{
document.write(lexico_globals.googleafc.ads.contenttop);
document.write(lexico_globals.googleafc.ads.sponsoredlinks);
document.write(lexico_globals.googleafc.ads.content[2]);
document.write( member of the Clinical delving Division at Fred Hutchinson Cancer study Center, reports these findings in the June 19 issue of the New England Journal of Medicine.

More: - The rest...